What stool softener should be used and what is the appropriate dosing?

Stool Softener Recommendation

Docusate sodium (the traditional "stool softener") should NOT be used—it is ineffective for constipation. Instead, use polyethylene glycol (PEG) 17 g daily as first-line therapy, which is both effective and affordable 1.

Why Docusate Fails

The term "stool softener" traditionally refers to docusate sodium, but multiple high-quality studies demonstrate it does not work:

• No physiological effect: Docusate at maximum recommended doses (300 mg/day) does not increase stool water content, stool weight, or bowel movement frequency in controlled trials 2
• Inferior to alternatives: Psyllium is superior to docusate for both stool softening (increased stool water content by 2.33% vs 0.01%, p=0.007) and laxative efficacy 3
• No benefit in hospice patients: Randomized controlled trial showed no difference between docusate plus sennosides versus placebo plus sennosides for any constipation outcome 4
• No benefit in cancer patients: Adding docusate 400-600 mg/day to sennosides was actually less effective than sennosides alone (62.5% vs 32% had adequate bowel movements, p<0.05) 5

Recommended First-Line Agent: Polyethylene Glycol (PEG)

Start with PEG 17 g daily 1:

• Mechanism: Osmotic laxative that effectively increases stool water content
• Dosing: 17 g daily initially, titrate based on symptom response with no clear maximum dose
• Cost: $10-45 per month
• Evidence: Durable response demonstrated over 6 months
• Side effects: Bloating, abdominal discomfort, and cramping (generally mild)

Alternative First-Line Options

If PEG is not tolerated or available:

Fiber (Psyllium)

• Dose: 14 g per 1,000 kcal of daily intake
• Cost: <$50/month
• Key requirement: Ensure adequate hydration as fiber intake increases
• Evidence: Proven superior to docusate for stool softening 3

Magnesium Oxide

• Dose: 400-500 mg daily (studies used 1,000-1,500 mg daily)
• Cost: <$50/month
• Caution: Avoid in renal insufficiency and pregnancy

Lactulose

• Dose: 15 g daily
• Cost: <$50/month
• Special consideration: Only osmotic agent studied in pregnancy
• Limitation: Bloating and flatulence may be problematic

When to Escalate

If first-line osmotic laxatives fail after adequate trial (2-4 weeks at appropriate doses):

Short-term/Rescue Therapy

• Bisacodyl: 5 mg daily (maximum 10 mg daily) 1
• Senna: 8.6-17.2 mg daily (maximum 4 tablets twice daily)
• Important caveat: Long-term safety and efficacy unknown; use for short-term or rescue only

Prescription Secretagogues (for chronic refractory constipation)

• Lubiprostone: 24 μg twice daily ($374/month)
• Linaclotide: 72-145 μg daily, up to 290 μg daily ($523/month)
• Plecanatide: 3 mg daily ($526/month)

Common Pitfalls to Avoid

1. Prescribing docusate: Despite its widespread use, it is ineffective and represents a missed deprescribing opportunity 6. In one study, 80% of patients already on docusate had it continued despite lack of efficacy.

2. Inadequate laxative coverage with opioids: 28% of patients on opioids receive either no laxatives or docusate monotherapy 6—both inadequate strategies. Always use effective osmotic or stimulant laxatives prophylactically with opioids.

3. Insufficient fiber hydration: When using fiber supplements, inadequate fluid intake can worsen constipation rather than improve it 1.

4. Premature escalation to expensive agents: Try adequate doses of PEG or other osmotic laxatives before moving to prescription secretagogues that cost >$500/month.

Practical Algorithm

1. Start PEG 17 g daily (or psyllium if preferred)
2. Titrate dose based on response over 1-2 weeks
3. Add or switch to alternative osmotic (magnesium oxide, lactulose) if PEG not tolerated
4. Add stimulant laxative (bisacodyl or senna) for short-term rescue if needed
5. Consider prescription secretagogues only for chronic refractory constipation after first-line agents fail

Never prescribe docusate sodium as a stool softener—the evidence clearly demonstrates it does not work 3, 2, 5, 4.